Literature DB >> 16166301

Essential role for Ras signaling in glioblastoma maintenance.

Sheri L Holmen1, Bart O Williams.   

Abstract

Malignant gliomas can be induced in mice through the combined expression of activated forms of both KRas and Akt in glial progenitor cells. To determine the reliance of these tumors on continued KRas signaling in vivo, we generated a viral vector that allows the expression of KRas to be controlled post-delivery. Tumor-free survival rates were compared between those animals with continued KRas expression and animals in which KRas expression was suppressed. KRas signaling was found to be required for the maintenance of these tumors in vivo; inhibition of KRas expression resulted in apoptotic tumor regression and increased survival. Subsequent reexpression of KRas reinitiated tumor growth, indicating that a percentage of the progenitor cells survived and retained tumorigenic properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166301     DOI: 10.1158/0008-5472.CAN-05-1173

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.

Authors:  Dean W Felsher
Journal:  Genes Cancer       Date:  2010-06

2.  Oncogenic KRAS promotes malignant brain tumors in zebrafish.

Authors:  Bensheng Ju; Wenbiao Chen; Brent A Orr; Jan M Spitsbergen; Sujuan Jia; Christopher J Eden; Hannah E Henson; Michael R Taylor
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

3.  Ink4a/Arf loss promotes tumor recurrence following Ras inhibition.

Authors:  Matthew W Vanbrocklin; James P Robinson; Kristin J Lastwika; Andrea J McKinney; H Michael Gach; Sheri L Holmen
Journal:  Neuro Oncol       Date:  2011-10-20       Impact factor: 12.300

Review 4.  Will kinase inhibitors make it as glioblastoma drugs?

Authors:  Ingo K Mellinghoff; Nikolaus Schultz; Paul S Mischel; Timothy F Cloughesy
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.

Authors:  Matthew W VanBrocklin; James P Robinson; Kristin J Lastwika; Joseph D Khoury; Sheri L Holmen
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-23       Impact factor: 4.693

6.  Contribution of tumor heterogeneity in a new animal model of CNS tumors.

Authors:  Fuyi Chen; Albert J Becker; Joseph J LoTurco
Journal:  Mol Cancer Res       Date:  2014-02-05       Impact factor: 5.852

7.  Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo.

Authors:  J P Robinson; M W Vanbrocklin; K J Lastwika; A J McKinney; S Brandner; S L Holmen
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

8.  Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways.

Authors:  Aparna Kaul; Jean H Overmeyer; William A Maltese
Journal:  Cell Signal       Date:  2006-11-28       Impact factor: 4.315

9.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

Review 10.  Genetically engineered mouse models of brain cancer and the promise of preclinical testing.

Authors:  Jason T Huse; Eric C Holland
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.